Coffee Consumption Linked to 40% Reduced Risk of Liver Cancer

This article originally appeared here.
Share this content:
Coffee Consumption Linked to Reduced Risk of Liver Cancer
Coffee Consumption Linked to Reduced Risk of Liver Cancer

(HealthDay News) -- Coffee consumption is associated with a 40% reduction in the risk of liver cancer, according to a meta-analysis published in the November issue of Clinical Gastroenterology and Hepatology.

Francesca Bravi, Ph.D., from Istituto di Ricerche Farmacologiche "Mario Negri" in Milan, and colleagues identified and performed a meta-analysis of 16 published case-control or cohort studies that examined the association between coffee consumption and liver cancer or hepatocellular carcinoma (HCC), comprising 3,153 cases of HCC.

The researchers found that coffee consumption was associated with a significantly lower risk of HCC (summary relative risk [RR], 0.60 compared with no coffee consumption). Compared with no coffee consumption, the risk was lower for both low consumption (summary RR, 0.72) and high consumption (summary RR, 0.44), with a cut-off between low and high consumption of one or three cups per day depending on study. One additional cup of coffee per day reduced risk (summary RR, 0.80). The association between coffee consumption and HCC risk was not associated with gender, alcohol consumption, or a history of hepatitis or liver disease.

"From this meta-analysis, the risk of HCC is reduced by 40% for any coffee consumption versus no consumption," Bravi and colleagues conclude.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs